Jump to section
To revolutionize healthcare research without personal information and improve global healthcare by enabling secure and easy data access.
Artificial Intelligence has the potential to speed up research and innovation in the medical field, but to do so, teams need access to large amounts of good data to train their systems. Segmed supplies simplified access to robust and anonymous medical research data, to help accelerate medical AI development and facilitate innovation in the space.
By partnering with healthcare businesses, Segmed obtains a wide range of medical data, which it de-identifies onsite before making it available to clients. Data sets are standardized and machine readable, making them usable for both standard research and AI-led investigations, as well as good training data for learning AIs.
Segmed has secured a substantial amount of investment that will accelerate development and help fund growth. The company recently launched Segmed Insight, a tool to help accelerate algorithm development pipelines by curating a team’s AI training datasets.
Freddie
Company Specialist at Welcome to the Jungle
Sep 2024
$10.4m
SERIES A
Nov 2022
$5.2m
SEED
This company has top investors
Martin Willemink
(Co-Founder & CEO)Was a Researcher at the Stanford University School of Medicine. Founded Mastin Design.
Cailin Hardell
(Co-Founder)Former CEO of the company. Worked at the Stanford Byers Center for Biodesign.
Jie Wu
(Co-Founder & Chief Data Officer)Worked as a Machine Learning Engineer at Facebook.
Wojciech Adam Koszek
(Co-Founder & CTO)Previously a Senior Software Engineer at Salesforce.